9th Annual Biomarkers Congress
Second Annual Pre-Clinical/Clinical Development of Immunotherapies and Vaccines
Renaissance Providence Hotel
5 Avenue of the Arts
Providence, RI
http://www.healthtech.com/imt/clv
Second Annual Pre-Clinical/Clinical Development of Immunotherapies and Vaccines

 Cambridge Healthtech Institute

Schedule of Presentations:

Tuesday, August 18, 2009
12:00:00 Fusion Protein Vaccine with Built-in Adjuvant Atsuo Ochi
12:30:00 IMMUNE RESPONSE BIOMARKERS
12:35:00 Registration
13:40:00 Chairperson’s Opening Remarks
13:45:00 A Systematic Approach to Biomarker Discovery: Preamble to “iSBTc-FDA Taskforce on Immunotherapy Biomarkers” Lisa H. Butterfield
14:15:00 Complexities of Clinical Assay Development and Optimization Prior to First-in-Man Immunization Trials - A Description of Immunogenicity Assay Development for the Testing of Samples from a Phase 1 Alzheimer’s Vaccine Trial Olivia Hammond
14:45:00 Development of Bioassays to Measure Immune Responses Sylvia Janetzki
15:15:00 Ice Cream Bar Refreshment Break with Exhibit and Poster Viewing
15:20:00 ENHANCING THE IMMUNE RESPONSE – PRECLINICAL CASE STUDIES
16:00:00 Chairperson's Remarks
16:30:00 Immunization via a Novel Intradermal Particle Delivery System Martin Brouillette
17:00:00 Preclinical Development of Broadly Protective Heat Shock Proteins Based Meningitis Vaccine Shawn McNulty
17:30:00 End of Day 1
Wednesday, August 19, 2009
07:30:00 Morning Coffee (Breakfast Sponsored Presentation Opportunity Available)
07:35:00 CASE STUDIES AND LESSONS LEARNED FROM PRECLINICAL AND CLINICAL DEVELOPMENT PROGRAMS
08:25:00 Chairperson’s Remarks Mark W. Frohlich
08:30:00 Of Mice & Men (and Dogs!): Xenogeneic DNA Vaccines for Cancer Philip J. Bergman
09:00:00 Vaccination in Combination with Multiple Immunomodulators Thomas Davis
09:30:00 The Development of BiovaxID: An Autologous Anti-idiotype Vaccine for the Treatment of Follicular non-Hodgkin’s Lymphoma Carlos F. Santos
10:00:00 Networking Coffee Break
10:30:00 Sipuleucel-T for the Treatment of Advanced Prostate Cancer: Recent Progress and Lessons Learned Mark W. Frohlich
11:00:00 Behavioral and Social Science Considerations for Clinical Research Chuen-Yen Lau
11:30:00 Recent Progress for the GeoVax Clade B DNA/MVA HIV/AIDS Vaccine Harriet L. Robinson
12:00:00 Sponsored Presentation (Opportunity Available)
12:15:00 Lunch on Your Own (Lunch Workshops Sponsorship Available)
13:40:00 Chairperson’s Remarks
13:45:00 Novel Immunotherapeutic Vaccine for Cardiovascular Disease Joanne Bedwell,
14:15:00 Expert Panel Discussion: Commonalities and Lessons Learned from Infectious Disease and Cancer Immunotherapy and Vaccine/Immunotherapy Development Programs Bruce L. Levine, Robert J. Binder, Ronald C. Kennedy
15:15:00 Networking Refreshment Break
15:20:00 PROACTIVE RISK MANAGEMENT IN VACCINE DEVELOPMENT PROGRAMS
15:30:00 A Therapeutic Vaccine for Cancers with Mutated ras; Integration of a Technology Platform, Target Selection and Clinical Development David Apelian
16:00:00 Risk Management in Vaccine Development Programs Adrian Dana
16:30:00 Proactive Risk Management During Development: Ways to Improve the Probability of Success Paul Coplan
17:00:00 End of Pre-Clinical/Clinical Development of Immunotherapies & Vaccines meeting
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.